Star Imaging IPO Day 3 Subscription at 5.67x – QIBs Lead the Rally

Star Imaging and Path Lab Limited's initial public offering (IPO) has demonstrated good investor interest through its third and final day of subscription, with Star Imaging's stock price set at ₹135-142 per share reflecting solid market reception. The ₹69.47 crore IPO reached 5.67 times by 5:04:32 PM on day three, indicating good investor interest in this diagnostic services company incorporated in 2004.

Star Imaging IPO qualified institutional buyers (ex-anchor) segment leads with solid 12.85 times subscription, whilst non-institutional investors demonstrate good participation at 4.38 times and individual investors show moderate interest at 2.32 times, whilst anchor investors show complete participation at 1.00 times, reflecting good investor confidence in this company.

Star Imaging IPO subscription reached good 5.67 times on day three, led by Qualified Institutional Buyers Ex-Anchor (12.85x), Non-Institutional Investors (4.38x), and Individual Investors (2.32x). Total applications reached 2,243.

Subscription Status of Star Imaging IPO:

Here are the subscription details for Star Imaging IPO as of Day 3 (August 12, 2025, 5:04:32 PM):

Star Imaging IPO Reservation

Key Highlights - Day 3:

• Overall subscription reached good 5.67 times, a significant improvement from day two's 0.28 times.
• Qualified institutional buyers (ex-anchor) showing solid performance at 12.85 times, building substantially from day two's 0.00 times.
• bNII category demonstrating good participation at 5.12 times, building significantly from day two's 0.36 times.
• Non-institutional investors category displaying good interest at 4.38 times, building notably from day two's 0.39 times.
• sNII segment showing moderate participation at 2.89 times, building substantially from day two's 0.43 times.
• Individual investors displaying moderate confidence at 2.32 times, building moderately from day two's 0.41 times.
• Employees showing limited interest at 0.31 times, building moderately from day two's 0.10 times.
• Total applications reached 2,243, indicating good investor participation for this SME IPO.
• Cumulative bid amount reached ₹250.16 crores against the issue size of ₹69.47 crores.

Star Imaging IPO - Day 2 Subscription at 0.28 Times

Key Highlights - Day 2:

• Overall subscription reaching 0.28 times, showing improvement from day one's 0.05 times.
• sNII category demonstrating modest performance at 0.43 times, building substantially from day one's 0.09 times.
• Individual investors showing moderate growth at 0.41 times, building significantly from day one's 0.05 times.
• Non-institutional investors category displaying improvement at 0.39 times, building notably from day one's 0.13 times.
• bNII segment showing modest participation at 0.36 times, building substantially from day one's 0.15 times.
• Employees showing limited interest at 0.10 times, building from day one's 0.00 times.
• QIB (ex-anchor) segment displaying no participation at 0.00 times, maintaining day one's 0.00 times.

Star Imaging IPO - Day 1 Subscription at 0.05 Times

Key Highlights - Day 1:

• Overall subscription reached 0.05 times, showing modest initial investor interest.
• bNII category demonstrating limited performance at 0.15 times, showing restrained larger HNI interest.
• Non-institutional investors showing modest performance at 0.13 times, demonstrating cautious HNI appetite.
• sNII segment showing limited interest at 0.09 times, indicating restrained smaller HNI participation.
• Individual investors displaying minimal interest at 0.05 times, showing cautious retail sentiment.
• QIB (ex-anchor) and employees segments displaying no participation at 0.00 times, showing wait-and-watch approach.

About Star Imaging and Path Lab Limited

Incorporated in 2004, Star Imaging and Path Lab Limited is an Indian healthcare diagnostics company engaged in providing imaging services including X-rays, ultrasounds, CT scans, MRIs and laboratory tests, specializing in radiology, pathology and diagnostic services with advanced technology and experienced medical professionals across multiple regions.